Steven Cohen’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
BBA
Steven Cohen's RYTM Position: Q3 2026 in Review
Steven Cohen increased its Rhythm Pharmaceuticals (RYTM) stake by 75% in Q3 2026, buying an estimated $33.3M and bringing the position to 726,499 shares worth $69.2M. The position accounts for 0.08% of the portfolio, ranked #316.
Steven Cohen first reported a position in RYTM in Q4 2017 and has held it in 10 quarters since. The position peaked at $73.6M in Q1 2026. 329 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- Steven Cohen held 726,499 shares of Rhythm Pharmaceuticals worth $69.2M as of Q3 2026.
- Steven Cohen bought 312,289 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $33.3M.
- Rhythm Pharmaceuticals made up 0.08% of Steven Cohen's portfolio in Q3 2026, its #316 holding.
- Steven Cohen first reported a position in Rhythm Pharmaceuticals in Q4 2017 and has held it in 10 quarters since.
- Steven Cohen's Rhythm Pharmaceuticals position peaked at $73.6M in Q1 2026.
- 329 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.